Market close: NZ stocks rise on back of big Wall St turnaround
An energetic Fisher and Paykel Healthcare led the way.
AdvertisementAdvertise with NZME.
Latest from Healthcare
Fisher & Paykel Healthcare to spend $275m on Karaka land for campus
"We need more space": Mega-development will roll out over decades.
F&P Healthcare expects sharp first half profit fall, shares plummet
F&P Healthcare sees earnings returning to pre-Covid levels in the first half to September.
Orion Health reveals measures to combat The Great Resignation
Snubbed at home, but contract wins offshore.
Covid-19 had a profound impact on F&P Healthcare, says CEO
Fisher & Paykel Healthcare's net profit dropped by 28 per cent to more normal levels.
F&P Healthcare net profit drops 28pc
The healthcare manufacturer withholds guidance for current year.
Result preview: What to expect from F&P Healthcare
F&P Healthcare is expected to report a sharp fall in annual net profit on Wednesday.
NZ dollar falls to near two-year low as Wall St plunge drags shares down
A further plunge on Wall Street dragged the NZ sharemarket down nearly 1 per cent.
NZ shares finish flat but retail and Ryman stocks flourish
The New Zealand sharemarket finished the week on a subdued note.
Market close: Investors offload Ryman, F&P Healthcare shares
The New Zealand sharemarket opened the week with more than a 1 per cent fall.
F&P Healthcare share price drops after revenue guidance
The previous year's revenue came to $1.97b.
Brokers' Picks: The hot stocks to watch in 2022
Results of the Herald's annual stock-picking game are in ... and the top picks for 2022.
Investors scramble after EBOS stock, shares rally sharply
EBOS Group's share placement as been well supported by the market.
F&P Healthcare H1 profit down 2%, beats market expectations
Fisher & Paykel Healthcare has released its first half result.
Preview: What to expect from F&P Healthcare's first-half result
Market's attention will be on what lies ahead as more countries come to grips with Covid.
F&P Healthcare's revenue edged back from Covid highs
F&P Healthcare's turnover edged lower in the first four months of its financial year.
Strong start to annual results fails to lift NZ sharemarket
For the second day running, the New Zealand sharemarket was driven down by F&P Healthcare.
Brokers' Picks: The best and worst performing shares at mid-year point
Mid-year results in the Herald Brokers Picks game don't all reflect the NZX-50 returns.
F&P Healthcare's shares plunge after record $524m profit
The respiratory products maker recorded a record profit of more than $500m.
Opinion: The exposures facing healthcare sector growth
F&P Healthcare and Ryman have been standouts among Australasian healthcare companies.
'Scandalous' $35m overspend on vaccine software? Ministry hits back
But IT leaders back Orion Health CEO Ian McCrae in his complaint to the Auditor-General.
The family pet helps drive Ebos net profit to new record
People spending more time with their pets helped drive up Ebos' first-half profit.
NZ imports fell sharply in 2020 - Stats NZ
NZ's imports plummeted in 2020 while exports remained strong, Stats NZ says.
Pandemic profits: F&P Healthcare shares climb on profit upgrade
New Zealand's largest listed company upgrades full-year profit again.
Brokers' Picks: The hot stocks to watch in 2021
Brokers select their top five companies for 2021 in our annual stock picking game.
Analysts ponder F&P Healthcare in a post-Covid world
F&P Healthcare's first-half profit leapt by 86 per cent, driven by Covid-19 demand.
Liam Dann: Despite vaccine news, war is far from over
Vaccine is no silver bullet but at least brings the horizons of this crisis into focus.
Market close: NZ shares end firmer, while FPH and a2 Milk ease
Trade thinned out before the long Labour Day weekend.
EBOS shares on a roll after Q1 profit lift
Shares in EBOS rallied after the company produced strong first quarter earnings.
Ebos Group posts record full-year result
Coronavirus pandemic did not negatively impact Ebos Group's FY20 result.
F&P Healthcare's huge earnings upgrade - is there more to come?
Could F&P Healthcare's earnings upgrade be too conservative?
F&P Healthcare stock rallies sharply on earnings update
F&P Healthcare said Covid-19 demand would drive earnings sharply higher in 2021.